| Quick Links: |
| :: WEDNESDAY, FEBRUARY 25, 2009 |
| :: THURSDAY, FEBRUARY 26, 2009 |
| :: FRIDAY, FEBRUARY 27, 2009 |
| :: SATURDAY, FEBRUARY 28, 2009 |
|
|
| WEDNESDAY, FEBRUARY 25, 2009 |
| 10:00 |
Registration opens |
| 14:30-18:30 |
Hall B |
Hall C |
|
Animas Workshop - 16:00-18:30
Glucose Management Tools: Clinical Implications of the Data (Speaker: Dr. Irl Hirsch)
- Blood Glucose Data Case Studies
- Insulin Pump Software Case Studies
- Continuous Glucose Monitoring Software Case Studies
* pre-registration is required |
Medtronic Diabetes Workshops
Workshop 1 - 14:30-15:30
CareLink Therapy Management Software (Speaker: Prof. Ohad Cohen) FULLY BOOKED
Workshop 2 - 16:00-17:00
CareLink Therapy Management Software (Speaker: Prof. Ohad Cohen) FULLY BOOKED
Workshop 3 - 17:30-18:30
CareLink Therapy Management Software (Speaker: Prof. Ohad Cohen) FULLY BOOKED
* pre-registration is required
** attendance is subject to approval by Medtronic |
|
18:30 |
Opening Ceremony - Hall A |
| Welcome greetings – Tadej Battelino |
| Honoring Prof. Christos Bartsocas – Moshe Phillip |
| Christos Bartsocas: Thirty-five centuries of Medical Education in Greece |
| |
Welcome Reception |
| |
|
THURSDAY, FEBRUARY 26, 2009 |
THURSDAY
MORNING
SESSION 1
08:30-09:55 |
SESSION 1 |
|
Jay Skyler: - Hall A
Immunotherapy of Type 1 Diabetes
|
|
HALL A:
SMBG – IMPACT ON DIABETIC CONTROL |
HALL B:
PATIENTS AND TECHNOLOGY |
|
Irl Hirsch:
SMBG frequency & titration guidelines for insulin treated subjects |
Lorry Laffel:
The use of new diabetes technologies in school and in the family |
|
Boris Kovatchev:
Glucose variability - clinical relevance, assessment, and control
|
Gerard Reach:
Prevention of diabesity – novel approach to tackle this problem
|
|
LECTURE SPONSORED BY BAYER
Stan Telson:
Information-based tools for patients using SMBG |
Deborah Christie:
Does technology motivate young people to manage diabetes
|
| 09:55-10:30 |
Coffee Break, Exhibition and Poster Viewing |
|
THURSDAY
MORNING
SESSION 2
10:30-11:30 |
SESSION 2:
ADVANCED APPROACHES TO OBESITY AND DIABETES (HALL A) |
|
Dimitrios A. Linos:
Bariatric surgical techniques and diabetes type 2 |
|
Scott Shikora:
NeuroModulation for the Treatment of Obesity and Metabolic Disorders
|
|
Elizabeth Rajan:
Endoscopic interventions for obesity - present and future |
|
THURSDAY
MORNING
SESSION 3
11:30-12:45 |
SESSION 3 – ORAL PRESENTATIONS |
|
HALL A: |
HALL B: |
|
E. Cengiz
C. Dalla Man
H. Zisser
J.K. Mader
R. Hovorka
Z. Landau |
A. Bohdjalian
A. Kaps
N. Kaufman
I. Rubinstein
S. Franc
J-P. Riveline |
| 12:45-13:30 |
Lunch Break |
|
THURSDAY
AFTERNOON
SESSION 4
13:30-15:10 |
SESSION 4 |
|
HALL A:
AIDPIT SYMPOSIUM |
HALL B:
P-CEZANNE SYMPOSIUM |
| SEVERE HYPOGLYCEMIA |
CENTRAL MONITORING SYSTEM FOR DIABETIC PATIENTS |
|
Stephanie Amiel:
Severe Hypoglycemia - Definition, Detection, Outcome & Impact
|
Louis Shenkman - MEIR:
Overview of status of implantable glucose monitors
|
|
Eric Renard:
Severe Hypoglycaemia: Solutions offered by Diabetes Technologies |
Igor Lacik - PISAS:
Application of polymeric materials in the design of implantable glucose biosensor
|
|
Marie-Christie Vantyghem:
Who Should Benefit from Islet Transplantation
|
Andrea Llobera – CNM:
Integrated full-field fluorescence biosensors based on hololow/sol-gel waveguides
|
|
Boris Kovatchev:
Can severe hypoglycemia be predicted and prevented?
|
Nissim Hai – AFI:
Central monitoring system for diabetic patients |
|
Ugo Boggi:
When should pancreas transplantation be considered?
|
Shula Michaeli - BIU:
Monitoring extracellular glucose levels by live cells |
| 15:10-15:40 |
Coffee Break, Exhibition and Poster Viewing |
|
THURSDAY
AFTERNOON
SESSION 5
15:40-16:40 |
SESSION 5 |
|
HALL A:
GLUCOSE VARIABILITY |
HALL B:
NEW FRONTIERS IN RESEARCH AND PRACTICE |
|
Franco Chiarelli:
Role of fasting and postprandial glycemic control on the development of diabetic complications
|
Natasa Ursic Bratina
The use of CSII with CGM as a treatment of choice |
|
Bruce Bode:
Hypoglycemia and Glycemic Variability: Is it harmful and can it be controlled?
|
Moshe Hod:
Towards new diagnostic criteria for the diagnosis of Gestational Diabetes - Update on HAPO Study
|
|
J. Hans DeVries:
Glycemic variability - much ado about nothing
|
LECTURE SPONSORED BY NOVO NORDISK,
Liat de Vries:
New insulin treatment options in Type 1 - emerging experience with NovoMix 70 |
|
17:00-19:30 |
COMPANY WORKSHOP |
| |
HALL B |
|
DexCom Workshop
Continuous Glucose Monitoring: Issues That Matter Patient Use and In-Hospital Applications
* pre-registration is required
Terry Gregg:
Evolution of Continuous Sensing: DexCom's History
Satish Garg:
Practical Insights into What Matters to Patients
Thomas Danne:
CGM: A tool for parents and children - The European Experience
Jeffrey Joseph:
Opportunities and Challenges for In-Hospital CGM
Jay S. Skyler & Panel:
Q&A
Hands-on Practicum and Reception to follow the program |
| |
|
|
|
FRIDAY, FEBRUARY 27, 2009 |
|
FRIDAY
MORNING
SESSION 6
08:30-09:55 |
SESSION 6 |
|
Michael Strano:
Tissue implantable biosensors based on single walled carbon nanotube near infrared fluorescence
|
|
HALL A:
TECHNOLOGY – HEALTH POLICY AND BENEFIT |
HALL B:
CONTINUOUS GLUCOSE MONITORING |
|
Thomas Danne:
Do we need centers of reference to implement new technologies in pediatric diabetes? |
Christos Zoupas:
The continuous use of real time glucose monitoring combined with insulin pump, as a mean to normalize clucose variability and HbA1c in IDDM
|
|
Satish Garg:
Health outcomes from CGM
|
Lois Jovanovic:
Utility of continuous glucose monitoring throughout pregnancy |
|
Francine Kaufman:
Promotion of healthy lifestyle for children
|
John Pickup:
Fluorescence: shedding light on glucose sensing
|
| 09:55-10:30 |
Coffee Break, Exhibition and Poster Viewing |
| 10:30-12:00
|
SESSION 7 – SPONSORED SATELLITE SYMPOSIUM – MEDTRONIC (Hall A)
Chairperson: Prof. Stephanie Amiel |
| The Pathway of Diabetes Care: Next Steps into the Future |
|
Prof Tadej Battelino:
Making the most of CGM Technology: Utilizing Clinical Evidence
Prof. Stephanie Amiel:
Closing the Gap Towards Closed Loop--The UK Experience
Dr. John Mastrototaro:
Realizing the Dream of Closed Loop: Medtronic's Next Generation Devices |
|
12:00-13:00 |
Lunch Break |
|
FRIDAY
AFTERNOON
SESSION 8
13:00-14:00 |
SESSION 8 – THE LOOP CLUB (Hall A) |
|
Bruce Buckingham/E Dassau:
The Stanford-UCSB-RPI-Sansum-Schneider progress towards a closed-loop
|
|
Moshe Phillip/Eran Atlas:
Subcutaneous close loop studies using the S.C. MD logic system |
|
Claudio Cobelli:
Subcutaneous model predictive control clinical trial powered by in silico studies |
| 14:00-15:00 |
JDRF Hellas Project
Coordinator: Asimina Mitrakou |
Asimina Mitrakou:
Introduction: Hypoglycemia during Exercise |
Andriani Vazaiou:
The advantages of Continuous Glucose Monitoring System (CGMS) on mountain climbing in young adults with Type 1 Diabetes |
|
Bruce Buckingham:
Conclusions: The use of Continuous Glucose Monitoring
|
| 15:00-15:30 |
Coffee Break, Exhibition and Poster Viewing |
| 15:30-17:00 |
SESSION 9 – SPONSORED SATELLITE SYMPOSIUM - ROCHE DIAGNOSTICS GmbH (HALL A)
From Information Management to Insulin Management
Chair: Satish Garg Co Chair: Andriani Gerasimidi-Vazeou |
|
Ewa Pankowska:
Information Management - The value in daily live of diabetes professionals and their patients.
Thomas Danne:
Daily live of diabetes patients - A need for special requirements in special situations.
Stuart Bootle/Michał Jeliński:
New solutions in pump therapy - Ways to improve Insulin Management in diabetes patients. |
| 17:00-19:00 |
|
HALL B: |
| |
Abbott Workshop:
CGM using FreeStyle Navigator in clinical practice - who, when and how?
Panel:
Gerard Reach
Jan Bolinder
Bruce Buckingham
|
| |
|
|
|
SATURDAY, FEBRUARY 28, 2009 |
|
SATURDAY
MORNING
SESSION I0
08:30-10:10 |
SESSION 10 |
|
HALL A:
AIDPIT SYMPOSIUM |
HALL B: |
| REPRODUCING INSULIN SECRETION |
ONGOING STUDIES - Supported by an Educational Grant from Nilimedix Ltd |
Roman Hovorka:
Physiology of insulin secretion: what is needed for restoration |
Irl Hirsch:
Implications of the CGM Studies: where are we now? |
Roger Lehmann:
How well do transplanted islet cells restore insulin secretion? |
Peter Chase/ Bruce Buckingham:
Pump shut off to prevent nocturnal hypoglycemia |
Chiara Dalla Man:
How can algorithm connecting glucose sensors to insulin deliver devices mimic insulin secretion? |
Tadej Battelino:
Issues with closing the loop - critical appraisal |
Paola Maffi:
How to improve islet transplantation in humans? |
Arleen Pinkos:
Realistic expectations of a closed-loop; the FDA perspective |
Udo Hoss:
Continuous glucose monitoring in the tissue. Do we really need to callibrate in-vivo? |
Revital Nimri:
Feasibility of intravenous closed loop with I.V. MD logic system in the diabetic swine |
|
SATURDAY
MORNING
SESSION 11
10:10-10:30 |
SESSION 11 |
|
HALL A: |
HALL B: |
|
Sponsored Lecture by Novo Nordisk |
Sponsored Lecture by Sanofi Aventis |
|
Giorgio Sesti:
Liraglutide: The first human GLP-1 analogue, for once daily adminsitration
|
Jay Skyler:
What’s Changed? The recently EASD / ADA Guidelines for the management of T2DM
|
| 10:30-11:00 |
Coffee Break, Exhibition and Poster Viewing |
|
SATURDAY
MORINING
SESSION 12
11:00-12:00 |
SESSION 12 – NOVEL STRATEGIES FOR TREATMENT OF OBESITY & DIABETES (Hall A) |
|
Jay Skyler:
Peptide hormones for obesity
|
|
Vincenzo Bacci:
Gastric balloon – clinical experience and metabolic effects |
|
Henry Buchwald:
Metabolic/bariatric surgery in the treatment of type 2 diabetes |
| 12:00-13:00 |
Lunch Break |
|
SATURDAY
AFTERNOON
SESSION 13
13:00-14:40 |
SESSION 13 – ORAL PRESENTATIONS |
| HALL A |
HALL B |
|
J.H. Ficker
E. Dassau
H. Cormerais
D. Cox
A. Smit
B. Whitelaw
L. Laffel
A. Caduff |
R. Schiel
T. Orban
W. Fendler
A. Abu-Libdeh
G. Vilk
Y. Zhao
M. Giménez
A. Langlois |
| 14:40-15:10 |
Coffee Break, Exhibition and Poster Viewing |
|
SATURDAY
AFTERNOON
SESSION 14
15:10-16:10 |
SESSION 14 – FRONTIERS IN DIABETES TECHNOLOGIES (Hall A) |
|
Christophe De Block:
Use of continuous glucose monitoring in critical illness/ICU |
|
George Eisenbarth:
Next generation genome sequencing: implications for type 1 diabetes |
|
Paolo Pozzilli:
CSII to protect residual beta cell function in type 1 diabetes
|
|
16:10-16:20 |
Closing remarks: Moshe Phillip |